Gonzales, Nathalie E.

HRN: 26-83-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/14/2025
03/21/2025
IV
170mg
Q6h
Abscess
Waiting Final Action 
03/15/2025
MUPIROCIN 2%, 15G (TUBE)
03/15/2025
03/22/2025
TOPICAL
Apply Generously
OD
Abscess, Lower Back
Waiting Final Action 
03/18/2025
CLINDAMYCIN 150MG (CAP)
03/18/2025
03/22/2025
ORAL
150mg
Every 6hours
Abscess, Lower Back
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: